Pharmacogenomics — clinical cases
29 questions
Sample cases
- Case 1
A 47-year-old woman has a pharmacogenomic panel showing CYP2D6 *4/*41. The laboratory report lists the allele activity values as *4 = 0 (no function) and *41 = 0.5 (decreased function).
Using the CPIC activity-score system, which CYP2D6 phenotype should be assigned?
- A.Poor metabolizer
- B.Intermediate metabolizer
- C.Normal metabolizer
- D.Indeterminate metabolizer
- Case 2
A 52-year-old man with knee osteoarthritis is prescribed tramadol 50 mg every 6 hours as needed. His pharmacogenomic report shows CYP2D6 *1/*1xN (more than two copies of a normal-function allele; activity score greater than 2.25). He takes no other medicines.
According to CPIC, what is the most appropriate recommendation?
- A.Give tramadol at half the usual dose because he converts it faster
- B.Change tramadol to codeine 30 mg every 6 hours as needed
- C.Use tramadol at the usual label dose because he will get better analgesia
- D.Avoid tramadol; use a non-opioid analgesic, or if an opioid is warranted, a non-codeine opioid
- Case 3
A 30-year-old man needs short-term analgesia after a wisdom-tooth extraction. The dentist wants to prescribe acetaminophen with codeine. A pre-emptive genotype shows CYP2D6 *1/*10. Allele values: *1 = 1 (normal function), *10 = 0.25 (decreased function). He has no other relevant history.
According to CPIC, which recommendation fits his result?
- A.Codeine may be used at the label-recommended adult dose
- B.Avoid codeine because he is an intermediate metabolizer
- C.Avoid codeine because he is an ultrarapid metabolizer
- D.Use codeine at half the label-recommended adult dose
